Cite
APA Citation
Smart, K., Bröske, A., Rüttinger, D., Mueller, C., Phipps, A., Walz, A., Ries, C., Baehner, M., Cannarile, M., & Meneses‐Lorente, G. (2020). pK/PD Mediated Dose Optimization of Emactuzumab, a CSF1R Inhibitor, in Patients With Advanced Solid Tumors and Diffuse‐Type Tenosynovial Giant Cell Tumor. Clinical pharmacology & therapeutics, 108(3), 616–624. http://access.bl.uk/ark:/81055/vdc_100106634735.0x00005a